Truist Securities Maintains Buy on Ovintiv, Lowers Price Target to $70

Benzinga Newsdesk www.benzinga.com Neutral 49.4%

Neg 0% Neu 49.4% Pos 0%

Truist Securities analyst Gabe Daoud maintains Ovintiv (NYSE:OVV) with a Buy and lowers the price target from $72 to $70.